| Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. | |
| | |
MedLine Citation:
|
PMID: 1091127 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Lowering blood lipids has been invoked as a means of controlling future coronary events. In this prospective study, the effect of a lipid-reducing agent clofibrate (2 gm. daily) on extent of coronary artery disease was investigated. Forty patients, 32 having aortocoronary bypass, six having Vineberg operations, two having neither, were placed double-blind in placebo (24 patients) and clofibrate (16 patients) groups, and restudied by selective coronary angiography one year later. An additional 24 patients dropped from the study due to adverse drug reactions in eight. Each patient's right, left, anterior descending, and circumflex coronary arteries (with their branches) were separately rated according to degree of obstruction. The clofibrate group showed a significantly greater fall in triglyceride than did the placebo group (minus 13.7 per cent versus plus 2.3 per cent; p equal to 0.45). In the clofibrate group, 19 out of 64 coronary arteries (29.6 per cent) showed progressive coronary narrowing, not significantly different from the placebo group (24 out of 96 coronary arteries narrowed, 25 per cent; p equal to 0.26). No significant differences between drug groups emerged when the data were corrected for degree of fall of blood lipids, initial lipoprotein type, or effect in bypassed versus nonbypassed vessels (p always greater than 0.2). Regression of coronary artery disease was not seen. We conclude that clofibrate did not significantly influence the rate of progression of coronary artery disease in a one-year period. |
| | |
Authors:
|
K Cohn; F J Sakai; M F Langston |
Related Documents
:
|
11481337 - Lipoprotein secretion and triglyceride stores in the heart. 20152247 - Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients wit... 11984217 - Wives of patients with acute myocardial infarction are at an increased risk of developi... 2685177 - Program on the surgical control of the hyperlipidemias (posch): design and methodology.... 12962417 - Successful emergency aortic valve replacement following percutaneous cardiopulmonary su... 20024847 - Left ventricular dysfunction and nt-probnp levels in patients with one-vessel disease a... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: American heart journal Volume: 89 ISSN: 0002-8703 ISO Abbreviation: Am. Heart J. Publication Date: 1975 May |
Date Detail:
|
Created Date: 1975-06-09 Completed Date: 1975-06-09 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 591-8 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arteriosclerosis
/
drug therapy,
mortality,
prevention & control Cholesterol / blood Clinical Trials as Topic Clofibrate / adverse effects, therapeutic use* Coronary Artery Bypass Coronary Disease / drug therapy, mortality, prevention & control* Drug Evaluation Humans Lipids / blood* Lipoproteins / blood Middle Aged Myocardial Revascularization Placebos Time Factors Triglycerides / blood |
| Chemical | |
Reg. No./Substance:
|
0/Lipids; 0/Lipoproteins; 0/Placebos; 0/Triglycerides; 57-88-5/Cholesterol; 637-07-0/Clofibrate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Age-related changes of cells involved in immune responses.
Next Document: Ultrasound in the diagnosis of congenital heart disease.